Signature Secures Scar Prevention Brief

Signature Secures Scar Prevention BriefSignature Healthcare Communications has been bought onboard by Cranage Healthcare to undertake the UK launch and ongoing promotion of its clinically proven scar prevention treatment, Kelo-cote®.

Kelo-cote® is an innovative topical silicone gel for the management of scars and for the prevention of more serious scars in the form of hypertrophic scars and keloids.  Recommended as a first line therapy by the “International Advisory Panel on Scar Management” it is also indicated for scars resulting from trauma, surgery or burns.

The agency will work with leading healthcare professionals from the field of dermatology to provide patient education about scar prevention and management, harnessing print, broadcast and digital PR to target core audiences.


Permalink: Signature Secures Scar Prevention Brief
Author: Signature Communications
Article Date: 03/06/2009